Sökresultat

Filtyp

Din sökning på "*" gav 549757 sökträffar

PPS at the P4EU conference

PPS, including LP3, attended the P4EU meeting earlier this summer at the Helmholtz Center for Infection Research in Braunschweig, Germany. P4EU (Protein Production and Purification Partnership in Europe, see external webpage) is a professional network, whose members engage in various aspects of protein expression, purification and characterization in academic settings such as universities or resea

https://www.lp3.lu.se/article/pps-p4eu-conference - 2025-10-27

LP3 participated in annual PPS retreat in Umeå

The distributed national research infrastructure Protein Production Sweden (PPS), where LP3 is included, met for its third annual staff retreat at Skeppsviks Herrgård near Umeå. The 23 staff researchers of PPS attending used the two day meeting to discuss and reflect about the first 2.5 years of PPS operations supporting more than 450 user projects so far, present new method developments in PPS an

https://www.lp3.lu.se/article/lp3-participated-annual-pps-retreat-umea - 2025-10-27

Lund University has selected LP3 to become a university platform

LP3 is one of three major university research infrastructures selected as university platforms by our rector. The appointment signals that these research infrastructures have high strategic importance for the entire university. The appointments are based on a number of criteria, for example the research infrastructures must have contributed to excellent research, offered broad accessibility for us

https://www.lp3.lu.se/article/lund-university-has-selected-lp3-become-university-platform - 2025-10-27

Free testing of Flow Induced Dispersion Analysis now at LP3

LP3 now has a demo unit of Fidabio (Fida Neo instrument) for Flow Induced Dispersion Analysis for protein sample quality, which is available for evaluation purposes the next 3 months. The analysis of sample gives an indication of the protein's health, oligomeric state/complex formation, if its monodisperse or aggregated and buffer compatibility etc. If you have any sample that you would like to kn

https://www.lp3.lu.se/article/free-testing-flow-induced-dispersion-analysis-now-lp3 - 2025-10-27

LP3 at the first SciLifeLab Lund retreat

Four of LP3’s staff participated in the first SciLifeLab Lund retreat in Båstad, 14 to 15th November 2024 with the theme: “Achieving Excellence Together”. The retreat was focused on giving the staff from all SciLifeLab site platforms the opportunity to get to know each other through presentations, group exercises and discussions. LP3 presented it’s capabilities in Lund, but also the national resea

https://www.lp3.lu.se/article/lp3-first-scilifelab-lund-retreat - 2025-10-27

Cell-free protein synthesis workshop January 2025

The Swedish NMR Centre in Gothenburg will host a workshop on cell-free protein synthesis, with special focus on applications in NMR spectroscopy. The workshop, which is held in Gothenburg 21-23 Jan 2025 will entail both lectures and practical wet lab work. The idea is that participants bring their own plasmid construct for expression, with possible isotope labelling to judge the outcome with 2D NM

https://www.lp3.lu.se/article/cell-free-protein-synthesis-workshop-january-2025 - 2025-10-27

Welcome to SciLifeLab seminars!

SciLifeLab Lund, which Lp3 is part of, arranges interesting seminars with presentations of its different units and local core facilities together with user presentations. So please take the opportunity to learn more of our different services which could be useful in you research. The SciLifeLab seminars are all given at 3 pm (15.00) in Belfragesalen at BMC D15, Klinkgatan 32, Lund. Most welcome! F

https://www.lp3.lu.se/article/welcome-scilifelab-seminars - 2025-10-27

LP3 Collaborates with New EU Research Project - VIGILANT

LP3 will provide capabilities within protein production, biophysical characterization and protein structure determination to help VIGILANT achieve its goals. VIGILANT: Targeting ER Import And Activation Of Viral Glycoproteins: Towards Broad-Spectrum AntiviralsLP3 will provide capabilities within protein production, biophysical characterization and protein structure determination to a new EU resear

https://www.lp3.lu.se/article/lp3-collaborates-new-eu-research-project-vigilant - 2025-10-27

LP3 at Tällberg Conference 2025

LP3 attended the 28th Swedish Conference on Macromolecular Structure & Function (SWEPROT) in Tällberg last weekend and presented our capabilities through several posters. Several PPS team members visited the meeting with around 130 other participants from the Swedish protein science community.More info on SWEPROT is found on the homepage (external).

https://www.lp3.lu.se/article/lp3-tallberg-conference-2025 - 2025-10-27

LP3 at the inagural conference of the new Linxs

Several LP3 members presented our capabilities with a poster at the first conference held in Linxs new facilities. The conference was held to celebrate the opening of the LINXS at Brunnshög in the newly build Loop (more info here on Linxs homepage). Several staff members of PPS visited the opening with many national and international participants interested in X-ray and neutron applications.

https://www.lp3.lu.se/article/lp3-inagural-conference-new-linxs - 2025-10-27

LP3 staff co-organised the 21st P4EU Meeting in Gothenburg, Sweden, 25-27th of August 2025

More than a hundred participants from all over Europe attended the three-day program with workshops, lectures and vendor presence to share knowledge in the field of protein production and purification. The P4EU (Protein Production and Purification Partnership in Europe; see external homepage) is a professional network, whose members engage in various aspects of protein expression, purification and

https://www.lp3.lu.se/article/lp3-staff-co-organised-21st-p4eu-meeting-gothenburg-sweden-25-27th-august-2025 - 2025-10-27

LP3 organized the fourth PPS staff retreat in Lund

The distributed national research infrastructure Protein Production Sweden (PPS), where LP3 is included, met for its fourth annual staff retreat at LINXS in Lund. The 27 staff researchers of PPS attending used the three-day meeting to discuss and reflect on the first 3.5 years of PPS operations delivering more than 1000 protein batches so far, present new method developments in PPS and plan furthe

https://www.lp3.lu.se/article/lp3-organized-fourth-pps-staff-retreat-lund - 2025-10-27

Collaborative research project on corona virus proteins

An international collaboration between the Lund Protein Production Platform (LP3), the UCL School of Pharmacy and ESS, through its DEMAX platform, has initiated biophysical and structural studies of three non-structural proteins from the novel coronavirus, SARS CoV-2, the causative agent of COVID-19. Recently we managed to solve the structure of one of these proteins, Nsp10, by using the BioMAX be

https://www.lp3.lu.se/article/collaborative-research-project-corona-virus-proteins - 2025-10-27

FragMAX awarded funding from the Swedish Research council

FragMAX, a project run in collaboration between LP3, MAXIV, Astra Zeneca and SARomics Biostructures, has been awarded funding from the Swedish Research Council. The project aims to establish a fragment based screening facility, enabling scientists and small companies to screen low molecular weight fragments for binding to target proteins using X-ray crystallography.Read more about the FragMAX proj

https://www.lp3.lu.se/article/fragmax-awarded-funding-swedish-research-council - 2025-10-27

Renewal of beamtime access at BioMAX and allocated time at SciLifeLab Cryo-EM facility

LP3 was successful in its application for renewal of beamtime access at BioMAX (the X-ray macromolecular crystallography beamline of MAX IV). The protein structure pipeline at LP3 is now established. Users can get their protein samples crystallised and the resulting crystals can on a regular basis be evaluated for diffraction and data can be collected. Processing of X-ray data and solving structur

https://www.lp3.lu.se/article/renewal-beamtime-access-biomax-and-allocated-time-scilifelab-cryo-em-facility - 2025-10-27